Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, will present data today demonstrating that its technology can detect rare full-length RNA transcript variants not picked up by other methods. Wobble’s technology utilised full-length RNA transcripts as biomarkers to achieve early-stage breast cancer detection with 80% sensitivity at 95% …
Wobble Genomics’ new tech demonstrates the power of RNA sequencing in identifying rare RNA transcript variants
Share.
